IMARC Group, a leading market research company, has recently releases report titled “Aortic Valve Replacement Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global aortic valve replacement market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the aortic valve replacement market?

Report Attributes


Market Size in 2022

US$ 9.1 Billion

Market Forecast in 2028

US$ 17.7 Billion

Growth rate (2023 to 2028)

CAGR of 11.68%

Base Year of the Analysis


Forecast Period


What are aortic valve replacement?

Aortic valve replacement is a medical procedure used to treat ailments impacting the valves that regulate blood flow within the heart. It helps reestablish normal blood circulation, minimize symptoms, extend life, and preserve heart muscle function. It is conducted through conventional open-heart surgery that involves cutting the chest or via minimally invasive (MI) approaches, which require minor incisions in the chest or a catheter placement through the leg. At present, key players are introducing artificial valves made from carbon-coated plastic or animal tissue sourced from cows, pigs, or donors across the globe.

Request for a free sample copy of this report:

What are the growth prospects and trends in the aortic valve replacement industry?

The global aortic valve replacement market is primarily driven by escalating demand for minimally invasive surgeries (MIS). Moreover, several favorable initiatives by governments of numerous countries to manage valvular diseases are positively influencing market growth. Additionally, the rising prevalence of valve stiffening and narrowing, especially among the senior population, has catalyzed market growth. Besides this, the availability of supportive reimbursement policies in healthcare facilities is another major growth-inducing factor. Furthermore, the rising number of approvals for innovative products is contributing to market growth. Apart from this, the increasing adoption of minimally invasive surgeries and the expanding geriatric population are propelling the market growth. Other factors, including rising incidences of valvular disorders, increasing awareness about replacement surgeries, and technological advancements, are also anticipated to drive the market further.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Surgery:

  • Open Surgery
  • Minimally Invasive Surgery

Breakup by Product:

  • Transcatheter Aortic Valve
  • Sutureless Valve
  • Others

Breakup by End Use:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including: 

  • Abbott Laboratories
  • Anteris Technologies Ltd.
  • Boston Scientific Corporation
  • Coroneo Inc.
  • CryoLife Inc.
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc.
  • LifeNet Health Inc.
  • LivaNova PLC
  • Medtronic plc
  • Thubrikar Aortic Valve Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal